Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Rating of “Moderate Buy” by Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has received a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $35.50.

A number of equities research analysts have weighed in on OPCH shares. UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $38.00 to $40.00 in a report on Wednesday. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. Finally, JMP Securities restated a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its stake in Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company’s stock valued at $448,118,000 after acquiring an additional 75,313 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after purchasing an additional 8,400,208 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company’s stock worth $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Northern Trust Corp boosted its holdings in Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company’s stock worth $60,934,000 after purchasing an additional 278,158 shares during the last quarter. Finally, Norges Bank bought a new stake in Option Care Health in the 4th quarter worth about $60,219,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Up 2.4 %

Shares of NASDAQ OPCH opened at $32.95 on Monday. The company’s 50 day moving average price is $33.35 and its 200-day moving average price is $28.85. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a market capitalization of $5.41 billion, a P/E ratio of 27.69, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same quarter in the prior year, the firm posted $0.26 earnings per share. The business’s quarterly revenue was up 16.3% compared to the same quarter last year. Equities analysts forecast that Option Care Health will post 1.22 earnings per share for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.